Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. | EVP of R&D | $1.64M | Jan 25, 2024 | ||
TIL | Instil Bio, Inc. | Chief Medical Officer | Mar 4, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|